Characterization of reemergent anti‐B red blood cell antibodies in a patient with recurrent acute myeloid leukemia with ABO‐incompatible allogeneic peripheral blood stem cell transplantation
Autor: | Eijiro Omoto, Riko Tsumanuma, Katsushi Tajima, Kazuya Takizawa, Hiroaki Kumagai, Takeshi Yasuda, Wataru Okumura, Shuhei Okuyama |
---|---|
Rok vydání: | 2019 |
Předmět: |
Myeloid
business.industry medicine.medical_treatment Immunology Acute erythroid leukemia Myeloid leukemia Hematology Hematopoietic stem cell transplantation 030204 cardiovascular system & hematology medicine.disease Isohemagglutinin 03 medical and health sciences Leukemia surgical procedures operative 0302 clinical medicine medicine.anatomical_structure hemic and lymphatic diseases ABO blood group system medicine Immunology and Allergy Bone marrow business 030215 immunology |
Zdroj: | Transfusion. 59:3319-3323 |
ISSN: | 1537-2995 0041-1132 |
DOI: | 10.1111/trf.15510 |
Popis: | Background Isohemagglutinins against ABO antigens absent on both recipient and donor red blood cells (RBCs) increase or decrease after ABO-incompatible hematopoietic stem cell transplantation (HSCT). However, few reports have described the changes in the isohemagglutinin titers and the characteristics in patients with recurrent hematologic conditions after ABO-incompatible HSCT. Case report A 59-year-old female with acute erythroid leukemia received a peripheral blood stem cell transplant from her HLA-haploidentical daughter. The patient was typed as group O with anti- A (4+) and B (4+) isohemagglutinins, while the donor was typed as group B. The bone marrow cells achieved complete donor cell chimerism on Day 13 after HSCT. On Day 120, the patient showed 97% B RBC type with persistent anti-A (3+) and without anti-B antibodies. On Day 375, her leukemia relapsed, and recipient type O RBCs and anti-B antibodies sequentially reemerged. However, clinicolaboratory hemolysis and erythroid aplasia were not detected in the patient. Results The post-HSCT sera agglutinated the allo B RBCs, but not the donor B RBCs, while the pre-HSCT sera agglutinated both RBCs. The burst-forming/colony-forming units of erythroid formation from the donor peripheral blood stem cells were impaired by only the pre-HSCT sera and not by the post-HSCT sera. Conclusion To our knowledge, this is the first report investigating the characteristic changes of isohemagglutinins between the pre- and post-HSCT sera in a patient with recurrent acute myeloid leukemia. The present study suggests that the plasma cells producing anti-donor B RBCs in the patient have been selectively eliminated or induced into an anergic state by the post-HSCT immunologic reconstruction. |
Databáze: | OpenAIRE |
Externí odkaz: |